Andere Sprachen Century Therapeutics, Inc.

Aktien

A3CSHU

US15673T1007

IPSC

Realtime-Estimate Cboe BZX Andere Börsenplätze 17:05:35 16.05.2024			% 5 Tage	% 1. Jan.
3,135 ^USD	+1,46 %		+3,45 %	-5,27 %

10.05.	Century Therapeutics präsentiert präklinische Daten, die die Fortschritte der Ipsc-Plattformtechnologie und der Programme auf der Jahrestagung 2024 der Asgct hervorheben	CI
09.05.	Century Therapeutics, Inc. meldet Ergebniszahlen für das erste Quartal zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting	13.05.
Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting	10.05.
Century Therapeutics Presents Preclinical Data Highlighting Advances in Ipsc Platform Technology and Programs At 2024 Asgct Annual Meeting	10.05.
Century Therapeutics : Corporate Overview May 2024	09.05.
Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates	09.05.
Century Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09.05.
Century Therapeutics to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit	24.04.
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit	23.04.
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit	23.04.
Syncona agrees to sell stake in investee company for GBP7.4 million	11.04.
Syncona to Sell Stake in Portfolio Company to Century Therapeutics	11.04.
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics	11.04.
Century Therapeutics Announces Plans to Expand Clinical Development for Its Lead Program, CNTY-101	11.04.
Century Therapeutics, Inc. acquired Clade Therapeutics, Inc. from Syncona Limited for $45 million..	11.04.
Century Therapeutics, Inc. announced that it expects to receive $59.999982 million in funding from a group of investors	11.04.
Century Therapeutics, Inc. agreed to acquire Clade Therapeutics, Inc. from Syncona Limited for $45 million.	11.04.
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research Annual Meeting	09.04.
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting	08.04.
Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference	19.03.
Sector Update: Health Care Stocks Retreating Late Afternoon	14.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Century Therapeutics, Inc.

Aktien

A3CSHU

US15673T1007

IPSC

Andere Sprachen

Filter